Financhill
Sell
45

NEUE Quote, Financials, Valuation and Earnings

Last price:
$6.87
Seasonality move :
-36.31%
Day range:
$6.80 - $6.91
52-week range:
$3.79 - $7.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
--
Volume:
2.6K
Avg. volume:
6.2K
1-year change:
34.98%
Market cap:
$61M
Revenue:
$936.7M
EPS (TTM):
-$22.00

Analysts' Opinion

  • Consensus Rating
    NeueHealth has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $7.00, NeueHealth has an estimated upside of 2.49% from its current price of $6.83.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $6.83.

Fair Value

  • According to the consensus of 1 analyst, NeueHealth has 2.49% upside to fair value with a price target of $7.00 per share.

NEUE vs. S&P 500

  • Over the past 5 trading days, NeueHealth has underperformed the S&P 500 by -0.27% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • NeueHealth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • NeueHealth revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter NeueHealth reported revenues of $215.8M.

Earnings Growth

  • NeueHealth has grown year-over-year earnings for 0 quarters straight. In the most recent quarter NeueHealth reported earnings per share of -$2.90.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
0.06x
EV / EBIT:
--
EV / Revenue:
1.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-11.05x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$201.2M
Return On Assets:
-15.76%
Net Income Margin (TTM):
-14.38%
Return On Equity:
-3241.93%
Return On Invested Capital:
-1375.06%
Operating Margin:
1.23%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $870.9M $1.1B $907.3M $245.1M $215.8M
Gross Profit $127.3M $172M $201.2M $48.2M $54.9M
Operating Income -$238M -$120.4M -$69.2M -$23.1M $2.7M
EBITDA -$255.8M -$518M -$70.1M $13.8M $8.9M
Diluted EPS -$189.29 -$130.73 -$22.00 -$3.53 -$2.90
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $1.5B $3.3B $3.8B $974.5M $788.2M
Total Assets $2.5B $5.3B $4.8B $1.1B $895.7M
Current Liabilities $1.2B $3.4B $4B $1.3B $1.1B
Total Liabilities $3B $3.4B $4B $1.3B $1.3B
Total Equity -$519.8M $1.8B $803.9M -$242M -$393M
Total Debt $200M -- $303.9M $66.4M $208.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$865.3M -$2.2B -$95.5M -$48.7M -$21M
Cash From Investing $890.2M $631.2M $51.7M $198.4M $63.2M
Cash From Financing $471.8M -$223.8M $19.3M -$275.5M -$2.7M
Free Cash Flow -$889.1M -$2.2B -$98.8M -$48.8M -$22.1M
NEUE
Sector
Market Cap
$61M
$33.5M
Price % of 52-Week High
89.16%
48.01%
Dividend Yield
0%
0%
Shareholder Yield
48.38%
-0.97%
1-Year Price Total Return
34.98%
-33.61%
Beta (5-Year)
--
0.621
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $6.84
200-day SMA
Buy
Level $6.31
Bollinger Bands (100)
Buy
Level 6.23 - 7.21
Chaikin Money Flow
Sell
Level -8.1K
20-day SMA
Sell
Level $6.85
Relative Strength Index (RSI14)
Buy
Level 50.10
ADX Line
Sell
Level 11.9
Williams %R
Neutral
Level -73.3333
50-day SMA
Buy
Level $6.82
MACD (12, 26)
Buy
Level 1.52
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 141

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-10.1681)
Sell
CA Score (Annual)
Level (-4.7752)
Buy
Beneish M-Score (Annual)
Level (-2.4168)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (13.509)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Stock Forecast FAQ

In the current month, NEUE has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NEUE average analyst price target in the past 3 months is $7.00.

  • Where Will NeueHealth Stock Be In 1 Year?

    According to analysts, the consensus estimate is that NeueHealth share price will rise to $7.00 per share over the next 12 months.

  • What Do Analysts Say About NeueHealth?

    Analysts are divided on their view about NeueHealth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NeueHealth is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is NeueHealth's Price Target?

    The price target for NeueHealth over the next 1-year time period is forecast to be $7.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is NEUE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for NeueHealth is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of NEUE?

    You can purchase shares of NeueHealth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NeueHealth shares.

  • What Is The NeueHealth Share Price Today?

    NeueHealth was last trading at $6.87 per share. This represents the most recent stock quote for NeueHealth. Yesterday, NeueHealth closed at $6.83 per share.

  • How To Buy NeueHealth Stock Online?

    In order to purchase NeueHealth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock